- Generic name
- Ondansetron
- Strength
- 8 mg/4 ml
- Dosage form
- Injection
- Manufactured by
- Rephco Pharmaceuticals Ltd.
Avoma Injection
About Avoma 8 mg/4 ml Injection
Avoma 8 mg/4 ml is a injection product of Rephco Pharmaceuticals Ltd. that contains Ondansetron. Only a doctor can decide whether it is suitable for a particular person.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Avoma 8 mg/4 ml Injection?
Avoma 8 mg/4 ml injection is a medicine made by Rephco Pharmaceuticals Ltd. Avoma 8 mg/4 ml injection is a medicine that belongs to a group called anti-emetics. It contains Ondansetron, which belongs to a group of anti-emetic drugs. The dose and course are decided by the doctor, and the injection is given by a healthcare professional.
Uses of Avoma
Only a doctor can decide whether it is suitable for a particular person. It helps manage these symptoms in adults and children. It is an anti-emetic medicine, which means it helps control vomiting. The doctor decides when it is appropriate and how it should be used as part of the overall treatment plan.
How to use Avoma
You should not try to give it to yourself. Do not inject it yourself unless a doctor has shown you how. Avoma is given as an injection by a healthcare professional. It can be taken with or without food. The doctor decides the dose and how long the course should last, based on the person's condition and needs. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Avoma
Rarely, serious allergic reactions, breathing difficulties, fast heartbeat, chest pain, or low potassium levels have been reported. If you notice any side effect or feel unwell, contact your doctor or pharmacist for advice. Tell your doctor if you notice any side effect that worries you or does not go away. Tell your doctor or nurse promptly if you feel unwell after the injection.
Safety and precautions
Ondansetron may mask symptoms of bowel obstruction, so your doctor will monitor you closely after abdominal surgery. The safety of this medicine in pregnancy has not been fully established with controlled studies, so tell the doctor if you are pregnant, think you may be pregnant or are breastfeeding. The safety of this medicine in pregnancy and breastfeeding is not fully established; studies in animals have not shown harm, but there are not enough studies in humans. The doctor will decide whether it is appropriate for you.
Frequently asked questions
What does Avoma treat?
Only a doctor can decide whether it is suitable for a particular person. It helps manage these symptoms in adults and children.
How do I use Avoma correctly?
You should not try to give it to yourself. Do not inject it yourself unless a doctor has shown you how.
Can Avoma cause side effects?
Rarely, serious allergic reactions, breathing difficulties, fast heartbeat, chest pain, or low potassium levels have been reported. If you notice any side effect or feel unwell, contact your doctor or pharmacist for advice.
Who should be careful with Avoma?
Ondansetron may mask symptoms of bowel obstruction, so your doctor will monitor you closely after abdominal surgery. The safety of this medicine in pregnancy has not been fully established with controlled studies, so tell the doctor if you are pregnant, think you may be pregnant or are breastfeeding.
Also available as
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.